Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

Fat tissue treatments may help with wound healing and hair growth, but more research with larger groups is needed to be sure.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

New treatments for lupus show promise, but more research is needed, especially for children.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Combining stress management and Minoxidil helps treat stress-related hair loss and improve well-being.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

The formulated gel is a promising treatment for alopecia areata.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Tandem repeats significantly influence hair color, especially darker shades, across different ancestries.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Hair loss in men is common, treatable, but not curable.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.